Prescription drug · ANDA
Primidone NDC 42291-509
Primidone 50 mg/1 · Tablet · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42291-509-50 | 42291050950 | 500 TABLET in 1 BOTTLE (42291-509-50)Marketed from Mar 22, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Primidone
- Generic name (nonproprietary)
- primidone
- Active ingredients
- Primidone — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- AvKARE
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040866
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 42291-509_51b5bdf4-6086-92aa-e063-6394a90abd1eSPL ID 51b5bdf4-6086-92aa-e063-6394a90abd1eSPL set ID e7a50a67-9653-463e-8c85-315b53f460c8RxCUI 96304, 198150UNII 13AFD7670Q
- Pharmacologic class
- Anti-epileptic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442291050950followed by a unit qualifier and the quantityPackage 42291-0509-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Primidone tablets used alone or concomitantly with other anticonvulsants, are indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040866
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Primidone | Primidone 50 mg/1 | TabletOral | Amneal Pharmaceuticals LLC | 65162-544 |
| Primidone | Primidone 250 mg/1 | TabletOral | Amneal Pharmaceuticals LLC | 65162-545 |
| Primidone | Primidone 50 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8206 |
| Primidone | Primidone 50 mg/1 | TabletOral | AvPAK | 50268-686 |
| Primidone | Primidone 250 mg/1 | TabletOral | AvPAK | 50268-687 |
| Primidone | Primidone 250 mg/1 | TabletOral | AvKARE | 42291-511 |
| Primidone | Primidone 50 mg/1 | TabletOral | Amneal Pharmaceuticals of New York LLC | 53746-544 |
| Primidone | Primidone 250 mg/1 | TabletOral | Amneal Pharmaceuticals of New York LLC | 53746-545 |
| Primidone | Primidone 50 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-7811 |